Patrick Lin - Jan 27, 2025 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Business - Strategy Off
Signature
/s/ Patrick Lin by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Jan 27, 2025
Transactions value $
$34,691
Form type
4
Date filed
1/29/2025, 04:20 PM
Previous filing
Aug 2, 2024
Next filing
Feb 18, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Purchase $34.7K +43.5K $0.80 43.5K Jan 27, 2025 Lin Family Trust Feb 4, 2024
holding PCSA Common Stock 29.1K Jan 27, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.